Contents

Search

cytokeratin 19 fragment in serum; CYFRA 21-1 in serum

Indications: - evaluation of prognosis & monitoring of non-small cell lung cancer Clinical significance: - elevated pretreatment levels may be associated with unfavorable prognosis - decreasing levels during therapy predict an objective response to treatment

Related

biomarkers for lung cancer screening keratin, type I cytoskeletal 19; cytokeratin-19; CK-19; keratin-19; K19 (KRT19)

General

cytokeratin 19 in serum/plasma

References

  1. ARUP Consult: CYFRA 21-1 (Cytokeratin 19 Fragment) in Lung Cancer https://arupconsult.com/ati/cyfra-21-1-cytokeratin-19-fragment-lung-cancer

Component-of

biomarkers for lung cancer screening